ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

YMI YM Biosciences Ordinary Shares (Canada)

0.00
0.00 (0.00%)
Share Name Share Symbol Market Type
YM Biosciences Ordinary Shares (Canada) AMEX:YMI AMEX Ordinary Share
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.00 -

- Report of Foreign Issuer (6-K)

10/01/2013 8:40pm

Edgar (US Regulatory)


 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

Form 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of January 2013

 

Commission File Number 1-32186

 


 

YM BioSciences Inc.

(Translation of registrant’s name into English)

 

Suite 400, Building 11

5045 Orbitor Drive

Mississauga, Ontario  L4W 4Y4
Canada

(Address of principal executive offices)

 


 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.)

 

Form 20-F o

 

Form 40-F x

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1)  o

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7)  o

 

 

 



 

INCORPORATION BY REFERENCE

 

This Form 6-K shall be incorporated by reference into the Prospectus and Registration Statement of YM BioSciences Inc. on Form S-8 (File No. 333-134410) and as an Exhibit to the Registration Statement of YM BioSciences Inc. on Form F-10 (File No. 333-175381).

 

DOCUMENTS FILED

 

See the Exhibit Index hereto for a list of the documents filed herewith and forming a part of this Form 6-K.

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

 

YM BIOSCIENCES INC.

 

 

 

By:

/s/ Leonard Vernon

 

Name:

Leonard Vernon

 

Title:

Vice President, Finance and
Administration

 

 

Date:  January 10, 2013

 

2



 

EXHIBIT INDEX

 

Exhibit

 

Description

 

 

 

99.1

 

Management Proxy Circular (including shareholder letter and notice of meeting)

99.2

 

Form of proxy

99.3

 

Letter of Transmittal for Common Shares

99.4

 

Letter of Transmittal for Warrants

99.5

 

Interim Order

99.6

 

Notice of Application

 

3


1 Year YM Biosciences Chart

1 Year YM Biosciences Chart

1 Month YM Biosciences Chart

1 Month YM Biosciences Chart